SEARCH BY TOPIC:

Find the content you are looking for on Diabetech by searching the desired device, company, or topic.

FDA Expands Tzield to Children Age 1+ to Delay Type 1 Diabetes

Apr 28, 2026

•

1 min read

FDA Expands Tzield to Children Age 1+ to Delay Type 1 Diabetes

Sanofi's disease-modifying therapy can now be used in children as young as 1 year old, opening a new window to delay type 1 diabetes progression in the youngest patients.

Itzel Estrada

First U.S. Insulin Pump Cleared for Pregnancy in Type 1 Diabetes

Apr 27, 2026

•

1 min read

First U.S. Insulin Pump Cleared for Pregnancy in Type 1 Diabetes

Tandem's Control IQ+ becomes the only commercially available automated insulin delivery system approved for pregnancy use in the U.S.

Itzel Estrada

Apr 27, 2026

•

1 min read

Why You’re Having Low Blood Sugar (And How to Prevent It)

I spoke with Gary Scheiner, CDCES, about why lows happen, how to treat them, and how to use your pump and CGM to reduce their frequency, duration, and severity.

Team Diabetech

Apr 24, 2026

•

1 min read

Eversense 365 Implantable CGM Officially Launches in Europe

The world's first one-year continuous glucose monitor is now available in Sweden, with Germany, Spain, and Italy to follow in the coming weeks.

Itzel Estrada

Sana Biotechnology and Mayo Clinic Team Up for Potential Type 1 Diabetes Cure

Apr 24, 2026

•

1 min read

Sana Biotechnology and Mayo Clinic Team Up for Potential Type 1 Diabetes Cure

The two have partnered to develop SC451, an investigational cell therapy aiming to restore the body’s ability to regulate glucose and eliminate the need for both insulin and immunosuppressive therapy.

Itzel Estrada

Apr 23, 2026

•

1 min read

Tandem Mobi Insulin Pump Flagged in FDA Recall Over Insulin Delivery Failure

The FDA has classified the Tandem Mobi insulin pump recall as Class I after a malfunction was found to disrupt insulin delivery and CGM communication.

Itzel Estrada